title: Effects of calcium-channel antagonists on tardive dyskinesia and psychosis.
authors.forename: L
authors.initials: L
authors.lastname: Adler
authors.forename: E
authors.initials: E
authors.lastname: Duncan
authors.forename: S
authors.initials: S
authors.lastname: Reiter
authors.forename: B
authors.initials: B
authors.lastname: Angrist
authors.forename: E
authors.initials: E
authors.lastname: Peselow
authors.forename: J
authors.initials: J
authors.lastname: Rotrosen
mesh_terms: D000328:Adult; D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004110:Diltiazem / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem